Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Net Sales
26.97
Other Operating Income
0.00
Total Operating income
26.97
Raw Material Cost
0.00
Purchase of Finished goods
8.32
(Increase) / Decrease In Stocks
0.17
Employee Cost
4.13
Power Cost
0.00
Manufacturing Expenses
-0.01
Selling and Distribution Expenses
0.00
Other Expenses
12.12
Total Expenditure (Excl Depreciation)
24.73
Operating Profit (PBDIT) excl Other Income
2.24
Other Income
0.61
Operating Profit (PBDIT)
2.85
Interest
-0.01
Exceptional Items
0.00
Gross Profit (PBDT)
2.86
Depreciation
1.56
Profit Before Tax
1.30
Tax
0.29
Provisions and contingencies
0.00
Profit After Tax
1.00
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
1.00
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
1.00
Equity Capital
16.49
Face Value
10.0
Reserves
0.00
Earnings per share (EPS)
0.61
Diluted Earnings per share
0.61
Operating Profit Margin (Excl OI)
8.31%
Gross Profit Margin
10.6%
PAT Margin
3.71%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 18.05%
Standalone Net Profit
QoQ Growth in quarter ended Mar 2026 is 138.10%
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 5.76%
Interest
QoQ Growth in quarter ended Mar 2026 is -133.33%
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Nephro Care With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
26.97
0
26.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
26.97
0
26.97
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
8.32
0
8.32
(Increase) / Decrease In Stocks
0.17
0
0.17
Employee Cost
4.13
0
4.13
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
12.12
0.00
12.12
Total Expenditure (Excl Depreciation)
24.73
0
24.73
Operating Profit (PBDIT) excl Other Income
2.24
0.00
2.24
Other Income
0.61
0
0.61
Operating Profit (PBDIT)
2.85
0
2.85
Interest
-0.01
0
-0.01
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2.86
0
2.86
Depreciation
1.56
0
1.56
Profit Before Tax
1.30
0
1.30
Tax
0.29
0
0.29
Provisions and contingencies
0.00
0
0.00
Profit After Tax
1.00
0
1.00
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
1.00
0
1.00
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1.00
0
1.00
Equity Capital
16.49
0
16.49
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.61
0
0.61
Diluted Earnings per share
0.61
0
0.61
Operating Profit Margin (Excl OI)
8.31%
0%
0.00
8.31%
Gross Profit Margin
10.60%
0%
0.00
10.60%
PAT Margin
3.71%
0%
0.00
3.71%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.75 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 18.05%
Quarterly - Standalone Net Profit
Standalone Net Profit 1.00 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 138.10%
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.02 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 5.76%
Quarterly - Interest
Interest -0.01 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -133.33%
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.55%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025






